Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study.

Per Soelberg Sorensen,Luigi Pontieri,Hanna Joensen, Alex Heick,Peter Vestergaard Rasmussen, Jakob Schäfer,Rikke Ratzer, Caroline Ellinore Pihl,Finn Sellebjerg,Melinda Magyari

Multiple sclerosis and related disorders（2022）

引用 5|浏览11

暂无评分

摘要

In this nationwide review of all Danish patients starting therapy with cladribine tablets in a real-world setting, cladribine treatment was safe, and the therapeutic response was as expected from previous clinical trials. A prolonged observation period is necessary to assess the long-term benefit and risk of cladribine.

查看译文

关键词

Cladribine,Cladribine tablets,Disease-modifying treatment,Multiple sclerosis,Relapsing-remitting multiple sclerosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要